SCHEMBL31026587

SCHEMBL31026587

CCCCc1ccc2ccc3cccnc3c2n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.60
CCR1 P32246 4/20 0.53
LMNA P02545 4/20 0.53
CCR5 P51681 3/20 0.53
CCR8 P51685 3/20 0.53
TSHR P16473 3/20 0.53
KDM4E B2RXH2 3/20 0.53
MAPT P10636 3/20 0.53
TDP1 Q9NUW8 3/20 0.53
HTT P42858 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
MMP2 P08253 2/20 0.53
GMNN O75496 1/20 0.53
TP53 P04637 1/20 0.53
HSP90AA1 P07900 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
MMP9 P14780 1/20 0.53
ALOX15 P16050 1/20 0.53
NFKB1 P19838 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4584933 1.00 PDE10A (0.60) PDE10ACCR1LMNACCR5CCR8
SCHEMBL9528545 0.95 PDE10A (0.58) PDE10ACCR1LMNACCR5CCR8
SCHEMBL31026595 0.94 PDE10A (0.57) PDE10ACCR1LMNACCR5CCR8
Hydrochloric Acid SCHEMBL28782888 0.94 PDE10A (0.57) PDE10ACCR1LMNACCR5CCR8
SCHEMBL27915486 0.94 PDE10A (0.57) PDE10ACCR1LMNACCR5CCR8
SCHEMBL31026567 0.94 PDE10A (0.57) PDE10ACCR1LMNACCR5CCR8
SCHEMBL28813000 0.94 PDE10A (0.57) PDE10ACCR1LMNACCR5CCR8
SCHEMBL10480813 0.94 PDE10A (0.57) PDE10ACCR1LMNACCR5CCR8
SCHEMBL27971229 0.94 PDE10A (0.57) PDE10ACCR1LMNACCR5CCR8
SCHEMBL30459407 0.86 CCR1 (0.54) PDE10ACCR1CCR5KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118389833-A Solvent extraction system for efficiently extracting and separating lithium 中国科学院过程工程研究所 2024-07-26 CN claimed
US-20260109717-A1 PHENANTHROLINE DERIVATIVE AND METHOD FOR PRODUCING PHENANTHROLINE DERIVATIVE TORAY INDUSTRIES, INC. (JP) 2026-04-23 US disclosed
CN-119143750-A Preparation method of N-ortho-alkyl substituted 1, 10-phenanthroline compound and catalyst prepared by same 中国石油化工股份有限公司 2024-12-17 CN disclosed
CN-118389833-A Solvent extraction system for efficiently extracting and separating lithium 中国科学院过程工程研究所 2024-07-26 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260109717-A1 PHENANTHROLINE DERIVATIVE AND METHOD FOR PRODUCING PHENANTHROLINE DERIVATIVE HPD, PAH, AHR PDE10A 3780/4885CCR1 1449/4885LMNA 1125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.